Filing Details

Accession Number:
0001567619-22-014297
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-21 16:09:25
Reporting Period:
2022-07-19
Accepted Time:
2022-07-21 16:09:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501989 Cytomx Therapeutics Inc. CTMX Pharmaceutical Preparations (2834) 273521219
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1645600 L. Alison Hannah C/O Cytomx Therapeutics, Inc.
151 Oyster Point Blvd., Ste. 400
South San Francisco CA 94080
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-07-19 15,000 $0.00 37,500 No 4 A Direct
Common Stock Disposition 2022-07-20 5,602 $1.42 31,898 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Represents Performance Stock Units ("PSUs") initially granted on October 24, 2021 that were subject to a performance-based vesting condition. The first milestone vesting condition was determined to be satisfied upon which 50% of the PSUs vested.
  2. Includes 22,500 restricted stock units.
  3. The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a PSU of the Issuer.